Alpha Teknova (TKNO) Total Non-Current Liabilities (2020 - 2025)

Alpha Teknova's (TKNO) quarterly Total Non-Current Liabilities came in at $34.8 million in Q4 2025, down 4.28% year-on-year from $36.4 million in Q4 2024, and little changed on a QoQ basis from $35.0 million in Q3 2025.

Alpha Teknova (TKNO) Total Non-Current Liabilities (2020 - 2025) Analysis & Trends

Alpha Teknova (TKNO) has 6 years of Total Non-Current Liabilities data on file, last reported at $34.8 million in Q4 2025.

  • On a quarterly basis, Total Non-Current Liabilities fell 4.28% year-over-year to $34.8 million in Q4 2025; TTM through Dec 2025 was $34.8 million, a 4.28% decrease from a year earlier, with the FY2025 full-year figure at $34.8 million, down 4.28% from the prior year.
  • Total Non-Current Liabilities for Q4 2025 stood at $34.8 million, roughly flat from $35.0 million in the prior quarter.
  • Over the last five years, Total Non-Current Liabilities for TKNO reached as high as $52.2 million in Q4 2022 and fell as low as $22.6 million in Q3 2021.
  • Historically, Total Non-Current Liabilities has averaged $38.0 million across 5 years, with a median of $36.8 million in 2024.
  • Across the five-year window, Total Non-Current Liabilities surged 126.81% in 2021 and decreased 26.32% in 2023, its largest moves.
  • Year by year, Total Non-Current Liabilities stood at $23.0 million in 2021, then surged by 126.55% to $52.2 million in 2022, then decreased by 26.32% to $38.4 million in 2023, then dropped by 5.42% to $36.4 million in 2024, then dropped by 4.28% to $34.8 million in 2025.
  • Per Business Quant data, the three most recent Total Non-Current Liabilities figures were $34.8 million in Q4 2025, $35.0 million in Q3 2025, and $34.4 million in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 14.92 Bn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 18.28 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 11.64 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 33.47 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 599.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 20.09 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 1.24 Bn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 6.26 Bn
10 Alpha Teknova 278.75 Mn 260.97 Mn 3.78 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 34.81 Mn
Sep 30, 2025 34.98 Mn
Jun 30, 2025 34.43 Mn
Mar 31, 2025 35.39 Mn
Dec 31, 2024 36.37 Mn
Sep 30, 2024 36.80 Mn
Jun 30, 2024 36.37 Mn
Mar 31, 2024 37.36 Mn
Dec 31, 2023 38.45 Mn
Sep 30, 2023 38.61 Mn
Jun 30, 2023 46.19 Mn
Mar 31, 2023 48.77 Mn
Dec 31, 2022 52.19 Mn
Sep 30, 2022 48.06 Mn
Jun 30, 2022 48.50 Mn
Mar 31, 2022 45.28 Mn
Dec 31, 2021 23.04 Mn
Sep 30, 2021 22.64 Mn
Jun 30, 2021 23.22 Mn
Dec 31, 2020 10.16 Mn